We are live on
!
Find out more
FPS
Fieldpoint Private Securities Portfolio holdings
AUM
$344M
Turnover
18.8%
1-Year Est. Return
7.21%
This Fund
S&P 500
This Quarter
Est. Return
+21.4%
1 Year Est. Return
-7.21%
3 Year Est. Return
+47.17%
5 Year Est. Return
+78.97%
10 Year Est. Return
–
AUM
$296M
AUM Growth
+$37M
(+14%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-4.07%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
305
New
65
Increased
86
Reduced
81
Closed
55
Avg Time Held Equity + Options
1.9
years
Top 10 Avg Time Held Equity + Options
1
year
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$3.18M |
| 2 |
SPDR Gold Trust
GLD
|
+$2.58M |
| 3 |
Tesla
TSLA
|
+$1.33M |
| 4 |
Becton Dickinson
BDX
|
+$1.25M |
| 5 |
Advanced Micro Devices
AMD
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$2.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.22M |
| 3 |
TJX Companies
TJX
|
+$1.4M |
| 4 |
Estee Lauder
EL
|
+$1.35M |
| 5 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 37.48% |
| 2 | Technology | 20.03% |
| 3 | Healthcare | 10.32% |
| 4 | Financials | 10.16% |
| 5 | Consumer Discretionary | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Eaton
ETN
$156B
| $280K | 0.09% |
+3,201
| New | +$264K |
2020 Q2
0 quarters
|
|
202
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
| $272K | 0.09% |
+6,966
| New | +$258K |
2020 Q2
0 quarters
|
|
203
NextEra Energy
NEE
$165B
| $272K | 0.09% |
4,532
+932
| +26% | +$55.8K |
2017 Q1
13 quarters
|
|
|
IMMU
204
DELISTED
Immunomedics Inc
IMMU
| $271K | 0.09% |
7,653
-14,497
| -65% | -$424K |
2019 Q2
4 quarters
|
|
205
Bristol-Myers Squibb
BMY
$124B
| $265K | 0.09% |
4,499
+688
| +18% | +$41.2K |
2017 Q3
11 quarters
|
|
206
BioMarin Pharmaceuticals
BMRN
$10.8B
| $256K | 0.09% |
2,075
-2,885
| -58% | -$287K |
2018 Q4
6 quarters
|
|
207
Humana
HUM
$51.9B
| $256K | 0.09% |
+661
| New | +$247K |
2020 Q2
0 quarters
|
|
208
Cirrus Logic
CRUS
$5.43B
| $252K | 0.09% |
+4,079
| New | +$279K |
2020 Q2
0 quarters
|
|
209
NXP Semiconductors
NXPI
$58.3B
| $250K | 0.08% |
+2,191
| New | +$219K |
2020 Q2
0 quarters
|
|
210
Philip Morris
PM
$312B
| $249K | 0.08% |
3,555
+138
| +4% | +$10.1K |
2017 Q1
13 quarters
|
|
211
Broadcom
AVGO
$1.64T
| $247K | 0.08% |
+7,830
| New | +$219K |
2020 Q2
0 quarters
|
|
212
Crane NXT
CXT
$3.12B
| $247K | 0.08% |
+11,959
| New | +$224K |
2020 Q2
0 quarters
|
|
213
Check Point Software Technologies
CHKP
$14.1B
| $246K | 0.08% |
+2,294
| New | +$243K |
2020 Q2
0 quarters
|
|
214
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| $243K | 0.08% |
+2,539
| New | +$233K |
2020 Q2
0 quarters
|
|
|
KSU
215
DELISTED
Kansas City Southern
KSU
| $243K | 0.08% |
1,631
+5
| +0.3% | +$703 |
2018 Q1
9 quarters
|
|
216
Ferrari
RACE
$69.9B
| $241K | 0.08% |
+1,414
| New | +$228K |
2020 Q2
0 quarters
|
|
217
Goldman Sachs
GS
$260B
| $238K | 0.08% |
+1,204
| New | +$226K |
2020 Q2
0 quarters
|
|
218
Rio Tinto
RIO
$147B
| $238K | 0.08% |
+4,228
| New | +$214K |
2020 Q2
0 quarters
|
|
219
Halliburton
HAL
$27.4B
| $237K | 0.08% |
+18,269
| New | +$197K |
2020 Q2
0 quarters
|
|
220
Biogen
BIIB
$34.8B
| $235K | 0.08% |
+877
| New | +$264K |
2020 Q2
0 quarters
|
|
221
Cardinal Health
CAH
$58.7B
| $234K | 0.08% |
+4,481
| New | +$231K |
2020 Q2
0 quarters
|
|
222
Dow Inc
DOW
$21.4B
| $234K | 0.08% |
+5,749
| New | +$210K |
2020 Q2
0 quarters
|
|
|
RVLP
223
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $226K | 0.08% |
+33,583
| New | +$164K |
2020 Q2
0 quarters
|
|
224
Wheaton Precious Metals
WPM
$60.5B
| $224K | 0.08% |
+5,096
| New | +$200K |
2020 Q2
0 quarters
|
|
225
KLA
KLAC
$228B
| $223K | 0.08% |
+11,450
| New | +$196K |
2020 Q2
0 quarters
|
|
Similar funds
BWM
IC
CP
MWM
TF
RIM
PPW
HA
Fieldpoint Private Securities's Q2 2020 Portfolio in Review
As of Q2 2020, Fieldpoint Private Securities held 305 positions worth $296M, up 14% from $259M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Fieldpoint Private Securities withdrew a net $12.1M in Q2 2020, closing 55 positions and reducing 81 holdings. Its most notable exit was TJX Companies, an estimated $1.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 36% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Fieldpoint Private Securities opened a new position in Intel worth $3.19M.
- Fieldpoint Private Securities's largest Q2 2020 buy was Intel: 53,257 shares worth $3.19M.
- Fieldpoint Private Securities added most to SPDR Gold Trust in Q2 2020, an estimated $2.58M increase.
- Fieldpoint Private Securities's biggest Q2 2020 reduction was iShares Floating Rate Bond ETF, cutting an estimated $2.4M.
- Fieldpoint Private Securities fully exited TJX Companies in Q2 2020, selling an estimated $1.4M.
- Fieldpoint Private Securities's ten largest holdings make up 24% of its $296M portfolio in Q2 2020.
- Fieldpoint Private Securities opened 65 new positions and closed 55 in Q2 2020.
- Fieldpoint Private Securities's portfolio value rose 14% quarter-over-quarter to $296M.
Based on Fieldpoint Private Securities's 13F filing for Q2 2020, filed 14 Aug 2020.